Listed

Cryo Cell International Inc: Form 10-Q for the period ended May 31, 2017

Filed with the SEC on Jul 7, 2017 and accepted by EDGAR at Jul 7, 2017, 21:04 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-05-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-03-01 to 2017-05-31$6.2mus-gaap:Revenues
Revenue6 months2016-12-01 to 2017-05-31$12.0mus-gaap:Revenues
Cost of revenue3 months2017-03-01 to 2017-05-31$1.6mus-gaap:CostOfServices
Cost of revenue6 months2016-12-01 to 2017-05-31$3.1mus-gaap:CostOfServices
Research and development3 months2017-03-01 to 2017-05-31$8.8kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-12-01 to 2017-05-31$23.5kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-03-01 to 2017-05-31$3.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2016-12-01 to 2017-05-31$6.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-03-01 to 2017-05-31$1.2mus-gaap:OperatingIncomeLoss
Operating income6 months2016-12-01 to 2017-05-31$2.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-03-01 to 2017-05-31$325.3kus-gaap:InterestExpense
Interest expense6 months2016-12-01 to 2017-05-31$622.4kus-gaap:InterestExpense
Income tax3 months2017-03-01 to 2017-05-31$331.7kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-12-01 to 2017-05-31$637.5kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-03-01 to 2017-05-31$496.9kus-gaap:NetIncomeLoss
Net income6 months2016-12-01 to 2017-05-31$983.9kus-gaap:NetIncomeLoss
Diluted EPS3 months2017-03-01 to 2017-05-31$0.06us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2016-12-01 to 2017-05-31$0.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-03-01 to 2017-05-31$0.07us-gaap:EarningsPerShareBasic
Basic EPS6 months2016-12-01 to 2017-05-31$0.14us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-03-01 to 2017-05-317,726,560 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2016-12-01 to 2017-05-317,582,535 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure6 months2016-12-01 to 2017-05-31$4.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2016-12-01 to 2017-05-31$403.9kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-05-31$4.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-05-31$10.7mus-gaap:AssetsCurrent
Total assetsAt period end2017-05-31$21.0mus-gaap:Assets
Current liabilitiesAt period end2017-05-31$13.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-05-31$35.3mus-gaap:Liabilities
Long-term debtAt period end2017-05-31$1.4mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2017-05-31−$14.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-17-224319. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.